![]() |
![]()
APPENDIX
B
![]()
Documents Referring To Discovery
Of Additional MKULTRA
Material
[document
begins] [View
JPEG Document Scan of This Page]
22 June
1977
MEMORANDUM FOR: Deputy Director of Central
Intelligence
THROUGH: Deputy Director for Science and
Technology
SUBJECT: Request for Guidance on Handling Recently
Located MKULTRA Material
1.
(U/AIUO) This memorandum is to advise you that additional MKULTRA
documents have been discovered and to obtain your approval for follow-on
actions required. Paragraph 7 contains a recommended course of
action.
2. (U/AIUO) As a result of
John Marks FOIA request (F-76-374), all of the MKULTRA material in OTS
possession was reviewed for possible release to him. Following that
review, the OTS material in the Retired Records Center was searched. It
was during that latter search that the subproject files were located among
the retired records of the OTS Budget and Fiscal Section. These files were
not discovered earlier as the earlier searches were limited to the
examination of the active and retired records of those branches considered
most likely to have generated or have had access to MKULTRA documents.
Those branches included: Chemistry, Biological, Behavioral Activities, and
Contracts Management. Because Dr. Gottlieb retrieved and destroyed all the
MKULTRA documents he was able to locate, it is not surprising that the
earlier search for MKULTRA documents, directed at areas where they were
most likely to be found, was unsuccessful. The purpose of establishing the
MKULTRA mechanism was to limit knowledge of the sensitive work being
performed to those with an absolute need to know. If those precepts had
been followed, the recently found B&F files should have contained only
financial and administrative documents. (In retrospect, I realize that
![]()
![]()
-104- [View
JPEG Document Scan of This Page]
SUBJECT: Request
for Guidance on Handling Recently Located MKULTRA Material
a
serious error was made in not having B&F files and other seemingly
innocuous files searched earlier.) As it happened most of the individual
subproject folders contain project proposals and memoranda for the record,
which in varying degrees, give a reasonably complete picture of the
avenues of research funded through MKULTRA. For your information, the
original memorandum setting up MKULTRA, signed by Mr. Dulles, is also
among these documents. A copy of the memorandum is
attached.
3. (U/AIUO) At this
writing, it does not appear that there is anything in these newly located
files that would indicate the MKULTRA activities were more extensive or
more controversial than indicated by the Senate Select (Church) Committee
Report. If anything, the reverse is true, i.e., most of the nearly 200
subprojects are innocuous. Thus, the overview of MKULTRA is essentially
unchanged. With two exceptions, the project find fills in some of the
missing details.
4. (U/AIUO) One of
these exceptions is Subproject Number 45 which concerns an activity that
should have been reported earlier. That project deals with the search for
a knockout drug which was concomitant with, and a by-product of, cancer
research at a major university. It is believed that an objective reading
of that project would demonstrate the search for knockout materials and
anesthetics were compatible activities. However, the research proposal
stated that "chemical agents... will be subjected to clinical screening...
on advanced cancer patients".
5. (C)
Subproject Number 55 contains full details of CIA's contribution of
$375,000 to the [deletion] Building Fund. The Agency was then involved in
drug research programs, many of which were being conducted by [deletion]
whose facilities were inadequate. In order to facilitate the ongoing
research programs, it was decided to expedite the building program by
contributing to it through a mechanism that was also being used to fund
some of the research projects.
![]()
![]()
-105- [View
JPEG Document Scan of This Page]
SUBJECT: Request
for Guidance on Handling Recently Located MKULTRA Material
The
contribution could be controversial in that it was made through a
mechanism making it appear to be a private donation. Private donations
qualified for, and [deletion] received, an equal amount of Federal
matching funds. A letter from the Office of General Counsel dated 21
February 1954 attesting to the legality of this funding is in the
file.
6. (U/AIUO) The Legislative
Counsel has been made aware of the existence of these additional MKULTRA
documents which are still under review and sanitation. The MARKS case is
in litigation and we are committed to advise Mr. Marks of the existence of
these files shortly, and to deliver the releasable material to his
attorneys by 31 July. A letter from the Information and Privacy Staff to
Mr. Marks' attorneys informing them of the existence of this material is
in the coordination process and is scheduled to be mailed on 24
June.
7. (U/AIUO) There are now two
actions that should be
taken:
a.
Release appropriately sanitized material to Mr. Marks' attorneys as
required by FOIA
litigation.
b.
Inform the Senate Select Committee of the existence of the recently
located records prior to informing Mr. Marks' attorneys.
It is
recommended that you approve of both of these
actions.
8. (U/AIUO) If additional
details on the contents of this material are desired, the OIS officers
most familiar with it are prepared to brief you at your
convenience.
[signature]
David S.
Brandwein
Director
Office of Technical
Service
[document ends]
![]()
![]()
-106- [View
JPEG Document Scan of This Page]
[document
begins]
The Director of Central
Intelligence
Washington, D.C. 20505
The Honorable Daniel
K. Inouye, Chairman
Select Committee on Intelligence
United States
Senate
Washington, D.C. 20510
Dear Mr.
Chairman:
During the course of 1975
when the Senate Committee, chaired by Senator Church, was investigating
intelligence activities, the CIA was asked to produce documentation on a
program of experimentation with the effect of drugs. Under this project
conducted from 1953 to 1964 and known as "MK-ULTRA," tests were conducted
on American citizens in some cases without their knowledge. The CIA, after
searching for such documentation, reported that most of the documents on
this matter have been destroyed. I find it my duty to report to you now
that our continuing search for drug related, as well as other documents,
has uncovered certain papers which bear on this matter. Let me hasten to
add that I am persuaded that there was no previous attempt to conceal this
material in the original 1975 exploration. The material recently
discovered was in the retired archives filed under financial accounts and
only uncovered by using extraordinary and extensive search efforts. In
this connection, incidentally, I have personally commended the employee
whose diligence produced this
find.
Because the new material now on
hand is primarily of a financial nature, it does not present a complete
picture of the field of drug experimentation activity but it does provide
more detail than was previously available to us. For example, the
following types of activities were
undertaken:
a.
Possible additional cases of drugs being tested on American citizens,
without their
knowledge.
b.
Research was undertaken on surreptitious methods of administering
drugs.
c.
Some of the persons chosen for experimentation were drug addicts or
alcoholics.
d.
Research into the development of a knockout or "K" drug was performed in
conjunction with being done to develop pain killers for advanced cancer
patients, and tests on such patients were carried out.
![]()
![]()
-107- [View
JPEG Document Scan of This
Page]
2
e.
There is a possibility of an improper payment to a private
institution.
The drug related activities described in this newly
located material began almost 25 years ago. I assure you they were
discontinued over 10 years ago and do not take place
today.
In keeping with the
President's commitment to disclose any errors of the Intelligence
Community which are uncovered, I would like to volunteer to testify before
your Committee on the full details of this unfortunate series of events. I
am in the process of reading the fairly voluminous material involved and
do want to be certain that I have a complete picture when I talk with the
Committee. I will be in touch with you next week to discuss when hearings
might be scheduled at the earliest
opportunity.
I regret having to bring
this issue to your attention, but I know that it is essential to your
oversight procedures that you be kept fully informed in a timely
manner.
Yours sincerely,
[signature]
STANSFIELD
TURNER
[document ends]
![]()
![]()
Appendix
A: Testing and Use of Chemical and Biological Agents by the
Intelligence Community
![]()
Appendix
C: Documents Referring to Subprojects
|
